Cargando…
OrBITS: label-free and time-lapse monitoring of patient derived organoids for advanced drug screening
BACKGROUND: Patient-derived organoids are invaluable for fundamental and translational cancer research and holds great promise for personalized medicine. However, the shortage of available analysis methods, which are often single-time point, severely impede the potential and routine use of organoids...
Autores principales: | Deben, Christophe, De La Hoz, Edgar Cardenas, Compte, Maxim Le, Van Schil, Paul, Hendriks, Jeroen M.H., Lauwers, Patrick, Yogeswaran, Suresh Krishan, Lardon, Filip, Pauwels, Patrick, Van Laere, Steven, Bogaerts, Annemie, Smits, Evelien, Vanlanduit, Steve, Lin, Abraham |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10060271/ https://www.ncbi.nlm.nih.gov/pubmed/36508089 http://dx.doi.org/10.1007/s13402-022-00750-0 |
Ejemplares similares
-
Unlocking the potential of CD70 as a novel immunotherapeutic target for non-small cell lung cancer
por: Jacobs, Julie, et al.
Publicado: (2015) -
The role of the surgeon in the management of oligometastatic non-small cell lung cancer: a literature review
por: Berzenji, Lawek, et al.
Publicado: (2021) -
Oxidative Stress-Inducing Anticancer Therapies: Taking a Closer Look at Their Immunomodulating Effects
por: Van Loenhout, Jinthe, et al.
Publicado: (2020) -
Minimally Invasive Surgery in Non-Small Cell Lung Cancer: Where Do We Stand?
por: Berzenji, Lawek, et al.
Publicado: (2023) -
Surgical Management of Stage IIIA Non-Small Cell Lung Cancer
por: Van Schil, Paul E., et al.
Publicado: (2017)